Sign In
Buy TNC
Tennant Company Earnings Calls
| Release date | May 04, 2026 |
| EPS estimate | $0.240 |
| EPS actual | $0.580 |
| EPS Surprise | 141.67% |
| Revenue estimate | 289.25M |
| Revenue actual | 297.9M |
| Revenue Surprise | 2.99% |
| Release date | Feb 23, 2026 |
| EPS estimate | $1.68 |
| EPS actual | $1.39 |
| EPS Surprise | -17.26% |
| Revenue estimate | 320.45M |
| Revenue actual | 291.6M |
| Revenue Surprise | -9.00% |
| Release date | Nov 03, 2025 |
| EPS estimate | $1.49 |
| EPS actual | $1.46 |
| EPS Surprise | -2.01% |
| Revenue estimate | 320.45M |
| Revenue actual | 303.3M |
| Revenue Surprise | -5.35% |
| Release date | Aug 06, 2025 |
| EPS estimate | $1.63 |
| EPS actual | $1.49 |
| EPS Surprise | -8.59% |
| Revenue estimate | 327.2M |
| Revenue actual | 318.6M |
| Revenue Surprise | -2.63% |
Last 4 Quarters for Tennant Company
Below you can see how TNC performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 06, 2025 |
| Price on release | $82.59 |
| EPS estimate | $1.63 |
| EPS actual | $1.49 |
| EPS surprise | -8.59% |
| Date | Price |
|---|---|
| Jul 31, 2025 | $82.54 |
| Aug 01, 2025 | $81.11 |
| Aug 04, 2025 | $82.74 |
| Aug 05, 2025 | $83.61 |
| Aug 06, 2025 | $82.59 |
| Aug 07, 2025 | $79.72 |
| Aug 08, 2025 | $80.30 |
| Aug 11, 2025 | $80.34 |
| Aug 12, 2025 | $83.11 |
| 4 days before | 0.0606% |
| 4 days after | 0.630% |
| On release day | -3.47% |
| Change in period | 0.691% |
| Release date | Nov 03, 2025 |
| Price on release | $79.62 |
| EPS estimate | $1.49 |
| EPS actual | $1.46 |
| EPS surprise | -2.01% |
| Date | Price |
|---|---|
| Oct 28, 2025 | $81.15 |
| Oct 29, 2025 | $81.19 |
| Oct 30, 2025 | $80.09 |
| Oct 31, 2025 | $80.00 |
| Nov 03, 2025 | $79.62 |
| Nov 04, 2025 | $75.29 |
| Nov 05, 2025 | $74.86 |
| Nov 06, 2025 | $74.46 |
| Nov 07, 2025 | $74.58 |
| 4 days before | -1.89% |
| 4 days after | -6.33% |
| On release day | -5.44% |
| Change in period | -8.10% |
| Release date | Feb 23, 2026 |
| Price on release | $82.30 |
| EPS estimate | $1.68 |
| EPS actual | $1.39 |
| EPS surprise | -17.26% |
| Date | Price |
|---|---|
| Feb 17, 2026 | $83.01 |
| Feb 18, 2026 | $83.31 |
| Feb 19, 2026 | $83.57 |
| Feb 20, 2026 | $83.37 |
| Feb 23, 2026 | $82.30 |
| Feb 24, 2026 | $63.02 |
| Feb 25, 2026 | $62.73 |
| Feb 26, 2026 | $62.33 |
| Feb 27, 2026 | $61.03 |
| 4 days before | -0.86% |
| 4 days after | -25.84% |
| On release day | -23.43% |
| Change in period | -26.48% |
| Release date | May 04, 2026 |
| Price on release | $81.95 |
| EPS estimate | $0.240 |
| EPS actual | $0.580 |
| EPS surprise | 141.67% |
| Date | Price |
|---|---|
| Apr 28, 2026 | $82.01 |
| Apr 29, 2026 | $81.10 |
| Apr 30, 2026 | $83.04 |
| May 01, 2026 | $82.78 |
| May 04, 2026 | $81.95 |
| May 05, 2026 | $82.63 |
| May 06, 2026 | $87.22 |
| May 07, 2026 | $86.99 |
| May 08, 2026 | $87.12 |
| 4 days before | -0.0732% |
| 4 days after | 6.31% |
| On release day | 0.83% |
| Change in period | 6.23% |
Tennant Company Earnings Call Transcript Summary of Q1 2026
Tennant reported Q1 2026 results showing recovering operations after a North America ERP implementation disruption. Orders rose 10% to $327M and backlog increased ~$32M, while net sales grew ~3% to $298M. Robotics (AMR) accelerated sharply: Q1 robotics revenue was ~$27M (85% YoY growth) and represented 9% of sales. Management emphasized stabilization of North America workflows with sequential gross margin improvement (Q1 enterprise exit ~40%), while estimating the ERP disruption reduced Q1 net sales by ~$23M and gross margin by ~$17M. The company reaffirmed full-year 2026 guidance: net sales $1.24–1.28B, adjusted EBITDA $175–190M, adjusted EPS $4.70–5.30, and expects results weighted to the second half of the year. Strategic moves include extending exclusivity with Brain Corp to 2029, launching two new AMR products (X16 SWEEP and X2 ROVR), planning 10 new AMR products in 24 months, targeting $250M AMR revenue by 2028, and opportunistic capital returns (Q1 buybacks of $60M; new authorization adding capacity ~2.56M shares total). Liquidity and leverage remain healthy (net leverage ~1.78x TTM EBITDA; ~$82.6M cash and ~$289M revolver capacity). Management expects gross margin to expand through 2026 as ERP issues are resolved, pricing actions persist, and productivity improves.
